Sun Pharma's Q2 nos draw price upgrades, stock hits 7-yr high https://ift.tt/YzEmcTA of India's largest pharmaceutical company, which surged to its seven-year high earlier on Wednesday, advanced 1.45% to close at ₹1,051.60. It touched a high of ₹1,070.95 before giving up some of its gains. Analysts have a median target price of ₹1,135.28 per share. That translates roughly into gains of 8.3% from the current market price.
Wednesday, November 2, 2022
Sun Pharma's Q2 nos draw price upgrades, stock hits 7-yr high | Economic Times
Subscribe to:
Post Comments (Atom)
-
Jeffersonville, OH - Join our 100% Owner Operator Fleet today! If you're tired of uncertain work, if fuel prices are killing your profit...
-
Rising Career Solution - Delhi - Walking interview & same day joining Urgent hiring for Credit Card Sales Vacancies- 300+ Payroll of Ind...
-
Genesis HealthCare - Florence, KY - Offering $2000 Sign On Bonuses for Full Time LPNs! Now Under New Leadership! Now offering OnShift! Acces...
No comments:
Post a Comment